Browse by Stream
QnA
Home
QnA
Go To Your Study Dashboard

Get Answers to all your Questions

header-bg qa
  • Home
  • Medical
  • In gene therapy of Adeosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:Option: 1 <

In gene therapy of Adeosine Deaminase (ADA) deficiency, the patient requires periodic infusion of genetically engineered lymphocytes because:

Option: 1

Gene isolated from marrow cells producing ADA is introduced into cells at embryonic stages.


Option: 2

Lymphocytes from patient's blood are grown in culture outside the body


Option: 3

Genetically engineered lymphocytes are not immortal cells.


Option: 4

Retroviral vector is introduced into these lymphocytes.


Answers (1)

best_answer

In ADA deficiency, lymphocytes are given but these cells are immortal and hence periodic infusion is needed. Option 2 is correct. 

Posted by

Rakesh

View full answer

NEET 2024 Most scoring concepts

    Just Study 32% of the NEET syllabus and Score up to 100% marks

Similar Questions

Trending Articles/News

anam-khan

NEET 2026: Odisha aspirant dies by suicide fearing failure
anam-khan

NEET 2026 Answer Key (Out) LIVE: Challenge window link at neet.nta.nic.in soon; result date, cutoff
anam-khan

NEET UG Answer Key 2026 (OUT) LIVE: NTA provisional keys out neet.nta.ac.in; challenge window opens soon

Latest Question